Myxoid Pattern
Coexists with different cellular components:
Spindle cell:
* Myxoma
* Low Grade Fibromyxoid Sarcoma
* Angiomyxoma
* Fibromyxoma
* Myxoid Liposarcoma
Pleomorphic:
* Myxofibrosarcoma
Prominent blood vessels:
* Angiomyxoma
* Myxoid Liposarcoma
Intramuscular myxoma
Multiple myxomas associated with:
* Carney complex
* Fibrous dysplasia (Mazabraud syndrome)
Micro:
* Hypocellular, composed of bland cells, no mitotic activity, no lipoblasts, scant blood vessels; may have focal histiocytes
* Slightly more cellular with collagenized capsule at periphery
* May have areas of increased vascularity or be hypercellular
* Slightly basophilic matrix with usually a few spindle cells at high power with oval nuclei
* May have central mucinous cyst
* At periphery, may infiltrate striated muscle and be associated with muscle atrophy
Molecular:
* GNAS1 mutations in 61% of intramuscular myxomas
IHC:
* Spindle cells: vimentin, CD34 (50%)
* Mucoid matrix: Alcian blue, mucicarmine, colloidal iron
* S100 -ve
* Desmin -ve
Low grade fibromyxoid sarcoma
Micro:
* Low to moderately cellular, bland fusiform or spindled cells with focal to diffuse whirling in heavily collagenized stroma with abrupt transition to myxoid areas
* Few collagenn rosettes are present
* 45% have epithelioid areas
* 40% contain poorly formed but large collagen rosettes
* Often infiltrates adjacent skeletal muscle
* Occasionally has areas of increased cellularity, atypia, necrosis or mitotic activity characteristic of intermediate to high grade sarcoma
* Recurrences may show increased cellularity and mitotic activity
Molecular:
* Characteristically expresses MUC4
* Has a t(7;16)(q32-34;p11) FUS-CREB3L2 fusion
IHC:
* MUC4 highly sensitive (100%) and specific
* CD99 (90%)
* BCL2 (90%)
* EMA
* vimentin (very nonspecific)